Halozyme Therapeutics Inc (HALO)
Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell
$71.58
Buy
$72.69
$-0.07 (-0.10%)
Prices updated at 06 Jun 2026, 00:52 EDT
| Prices minimum 15 mins delay
Prices in USD
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary p ...
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Biotechnology
Chairman
Mr. Jeffrey W. Henderson
CEO
Dr. Helen I. Torley, M.R.C.P.,MB.Ch.B.
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
423
Head office
12390 El Camino Real
San Diego
United States
92130
Key personnel
Owner name | Salary |
|---|---|
Mr. David A. Ramsay Interim Chief Financial Officer | - |
Mr. Jeffrey W. Henderson Chairman of the Board | 0.14m |
Dr. Helen I. Torley, M.R.C.P.,MB.Ch.B. Director, President and Chief Executive Officer | 1.00m |
Mr. Matthew L. Posard Independent Director | 0.08m |
Ms. Barbara G. Duncan Independent Director | 0.09m |
Ms. Bernadette M. Connaughton Independent Director | 0.07m |
Mr. Mark Snyder Senior Vice President, General Counsel, Chief Compliance Officer, Chief Legal Officer and Secretary | 0.62m |
Dr. Mahesh Krishnan, M.B.A. Independent Director | 0.06m |
Ms. Cortney Caudill Senior Vice President and Chief Operating Officer | 0.56m |
Mr. James Lang Independent Director | 0.00m |
Top 5 shareholders
Owner name | No. of shares |
|---|---|
| BlackRock Inc | 13,265,053 |
| Vanguard Group Inc | 11,566,896 |
| BlackRock Fund Advisors | 8,264,511 |
| Vanguard Capital Management, LLC | 5,271,218 |
| Vanguard Portfolio Management, LLC | 5,249,206 |
Director dealings
Date | Action |
|---|---|
| 09 Dec 2025 | - |
| 01 Dec 2025 | - |
| 01 Dec 2025 | - |
| 01 Dec 2025 | - |
| 01 Dec 2025 | - |
| 01 Dec 2025 | - |
| 01 Dec 2025 | - |
| 01 Dec 2025 | - |
| 26 Nov 2025 | - |
| 10 Nov 2025 | - |
| 11 Nov 2025 | - |
| 11 Nov 2025 | - |
| 10 Nov 2025 | - |
| 10 Nov 2025 | - |
| 12 Nov 2025 | - |
| 11 Nov 2025 | - |
| 10 Nov 2025 | - |
| 12 Nov 2025 | - |
| 12 Nov 2025 | - |
| 12 Nov 2025 | - |
Please note that past performance is not a reliable indicator of future returns.
